Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126479142 | 12647914 | 2 | F | 20160522 | 20160829 | 20160812 | 20160902 | EXP | US-PFIZER INC-2016380497 | PFIZER | 71.00 | YR | M | Y | 0.00000 | 20160902 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126479142 | 12647914 | 1 | PS | EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | 1 | 75 MG, 1X/DAY | 525 | MG | 20699 | 75 | MG | PROLONGED-RELEASE CAPSULE | QD | |||||
| 126479142 | 12647914 | 2 | SS | EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | 1 | 525 | MG | 20699 | PROLONGED-RELEASE CAPSULE | |||||||||
| 126479142 | 12647914 | 3 | SS | NORTHERA | DROXIDOPA | 1 | Oral | 300 MG, 3X/DAY | 25200 | MG | 0 | 300 | MG | CAPSULE | TID | ||||
| 126479142 | 12647914 | 4 | SS | NORTHERA | DROXIDOPA | 1 | 25200 | MG | 0 | CAPSULE | |||||||||
| 126479142 | 12647914 | 5 | SS | NORTHERA | DROXIDOPA | 1 | 25200 | MG | 0 | CAPSULE | |||||||||
| 126479142 | 12647914 | 6 | C | SINEMET | CARBIDOPALEVODOPA | 1 | UNK, 3X/DAY (CARBIDOPA: 25, LEVODOPA:100) | 0 | TID | ||||||||||
| 126479142 | 12647914 | 7 | C | AZILECT | RASAGILINE MESYLATE | 1 | 1 MG, 1X/DAY | 195 | MG | 0 | 1 | MG | QD | ||||||
| 126479142 | 12647914 | 8 | C | HALCION | TRIAZOLAM | 1 | UNK, 1X/DAY | 0 | TABLET | QD | |||||||||
| 126479142 | 12647914 | 9 | C | FLORINEF ACETATE | FLUDROCORTISONE ACETATE | 1 | 0.1 MG, 2X/DAY | 0 | .1 | MG | BID | ||||||||
| 126479142 | 12647914 | 10 | C | ATIVAN | LORAZEPAM | 1 | 0.5 MG, 1X/DAY | 0 | .5 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126479142 | 12647914 | 1 | Anxiety |
| 126479142 | 12647914 | 2 | Depression |
| 126479142 | 12647914 | 3 | Parkinson's disease |
| 126479142 | 12647914 | 4 | Orthostatic hypotension |
| 126479142 | 12647914 | 5 | Syncope |
| 126479142 | 12647914 | 6 | Parkinson's disease |
| 126479142 | 12647914 | 7 | Parkinson's disease |
| 126479142 | 12647914 | 8 | Insomnia |
| 126479142 | 12647914 | 9 | Orthostatic hypotension |
| 126479142 | 12647914 | 10 | Anxiety |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126479142 | 12647914 | DE |
| 126479142 | 12647914 | OT |
| 126479142 | 12647914 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126479142 | 12647914 | Anxiety | |
| 126479142 | 12647914 | Death | |
| 126479142 | 12647914 | Fatigue | |
| 126479142 | 12647914 | Hypokinesia | |
| 126479142 | 12647914 | Malaise | |
| 126479142 | 12647914 | Pyrexia | |
| 126479142 | 12647914 | Rash generalised | |
| 126479142 | 12647914 | Tremor |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126479142 | 12647914 | 1 | 20160516 | 20160522 | 0 | |
| 126479142 | 12647914 | 3 | 20160425 | 20160522 | 0 | |
| 126479142 | 12647914 | 7 | 20151110 | 20160522 | 0 | |
| 126479142 | 12647914 | 8 | 2000 | 0 | ||
| 126479142 | 12647914 | 9 | 201511 | 20160522 | 0 |